Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT00697333
Eligibility Criteria:
Inclusion Criteria:
* histologically proved NSCLC
* UICC-stage I-III, no resection planned
* complete staging \< 6 wks before treatment including cranial CT
* ECOG \<3, Karnofsky-Index \>60%
* age \> 18 \<
* FEV1 \> 1,0 l or \>35%
* RT-planning according to protocol feasible
* chemotherapy feasible
* written informed consent
Exclusion Criteria:
* neuroendocrine tumors, plain broncho-alveolar-cell ca.
* distant metastases, supraclavicular lymph node metastases
* malignant pleural effusion
* resection of actual tumor performed
* inclusion in other study protocol
* chemotherapy due to actual tumor before FDG-PET
* induction-chemotherapy
* acute vena cava superior syndrome
* second malignancy other than basalioma
* pregnancy, lactation
* heart insufficiency NYHA III/IV
* pneumoconiosis with active inflammatory changes of mediastinal lymph nodes
* acute broncho-pulmonary infection at time of PET-examination
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00697333
Study Brief:
Protocol Section:
NCT00697333